Cadila's Q1 cost-savings is impressive, but the stock's run-up may cap upside
Cadila's revenue growth has been propelled by a sharp growth in US revenues, which jumped 19% year-on-year (y-o-y)05-08-2020
05-08-2020
CADILA HEALTHCARE LTD. - 532321 - Unaudited Financial Results For The Quarter Ended On June 30, 2020
Unaudited Financial Results for the quarter ended on June 30, 202005-08-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
'Zydus Cadila announces Completion of Dosing in Phase I Clinical Trial of ZyCov-D'05-08-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication with regard to Notice of AGM, Book Closure and e-voting instructions.04-08-2020
Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term
Mitessh Thakkar of mitesshthakkar.com suggests buying Cadila Health with a stop loss of Rs 388, target at Rs 406 and Motherson Sumi with a stop loss of Rs 96, target at Rs 101.04-08-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives tentative approval from the USFDA for Carbidopa and Levodopa Extended-Release Capsules01-08-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst Call on August 5, 202028-07-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication with regard to notice of board meeting28-07-2020
CADILA HEALTHCARE LTD. - 532321 - Board Meeting Intimation for Considering The Unaudited Financial Results For The Quarter Ended On June 30, 2020.
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2020 ,inter alia, to consider and approve The unaudited financial results for the quarter ended on June 30, 2020.27-07-2020